Annual CFF
-$61.09 M
+$126.41 M+67.42%
December 31, 2023
Summary
- As of February 7, 2025, MRVI annual cash flow from financing activities is -$61.09 million, with the most recent change of +$126.41 million (+67.42%) on December 31, 2023.
- During the last 3 years, MRVI annual CFF has fallen by -$114.30 million (-214.80%).
- MRVI annual CFF is now -214.80% below its all-time high of $53.21 million, reached on December 31, 2020.
Performance
MRVI Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$809.00 K
+$581.00 K+254.82%
September 30, 2024
Summary
- As of February 7, 2025, MRVI quarterly cash flow from financing activities is $809.00 thousand, with the most recent change of +$581.00 thousand (+254.82%) on September 30, 2024.
- Over the past year, MRVI quarterly CFF has increased by +$26.00 thousand (+3.32%).
- MRVI quarterly CFF is now -98.01% below its all-time high of $40.67 million, reached on December 31, 2020.
Performance
MRVI Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$947.00 K
+$26.00 K+2.82%
September 30, 2024
Summary
- As of February 7, 2025, MRVI TTM cash flow from financing activities is $947.00 thousand, with the most recent change of +$26.00 thousand (+2.82%) on September 30, 2024.
- Over the past year, MRVI TTM CFF has increased by +$128.63 million (+100.74%).
- MRVI TTM CFF is now -98.22% below its all-time high of $53.21 million, reached on December 31, 2020.
Performance
MRVI TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MRVI Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +67.4% | +3.3% | +100.7% |
| 3 y3 years | -214.8% | +3.3% | +100.7% |
| 5 y5 years | -566.4% | +3.3% | +100.7% |
MRVI Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +67.4% | at high | +101.2% | at high | +100.5% |
| 5 y | 5-year | -214.8% | +67.4% | -98.0% | +101.2% | -98.2% | +100.5% |
| alltime | all time | -214.8% | +67.4% | -98.0% | +101.2% | -98.2% | +100.5% |
Maravai LifeSciences Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $809.00 K(+254.8%) | $947.00 K(+2.8%) |
| Jun 2024 | - | $228.00 K(-140.7%) | $921.00 K(-102.2%) |
| Mar 2024 | - | -$560.00 K(-219.1%) | -$42.44 M(-30.5%) |
| Dec 2023 | -$61.09 M(-67.4%) | $470.00 K(-40.0%) | -$61.09 M(-52.2%) |
| Sep 2023 | - | $783.00 K(-101.8%) | -$127.68 M(-23.0%) |
| Jun 2023 | - | -$43.13 M(+124.6%) | -$165.91 M(-0.2%) |
| Mar 2023 | - | -$19.21 M(-70.9%) | -$166.19 M(-11.4%) |
| Dec 2022 | -$187.50 M | -$66.12 M(+76.6%) | -$187.50 M(+9.7%) |
| Sep 2022 | - | -$37.44 M(-13.7%) | -$170.96 M(-7.5%) |
| Jun 2022 | - | -$43.41 M(+7.1%) | -$184.80 M(+5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$40.52 M(-18.3%) | -$175.51 M(+10.4%) |
| Dec 2021 | -$159.05 M(-398.9%) | -$49.58 M(-3.3%) | -$159.05 M(+131.2%) |
| Sep 2021 | - | -$51.28 M(+50.3%) | -$68.80 M(+272.8%) |
| Jun 2021 | - | -$34.13 M(+41.9%) | -$18.46 M(-224.6%) |
| Mar 2021 | - | -$24.06 M(-159.2%) | $14.81 M(-72.2%) |
| Dec 2020 | $53.21 M(-1377.0%) | $40.67 M(-4413.0%) | $53.21 M(+324.3%) |
| Sep 2020 | - | -$943.00 K(+10.2%) | $12.54 M(-7.0%) |
| Jun 2020 | - | -$856.00 K(-106.0%) | $13.48 M(-6.0%) |
| Mar 2020 | - | $14.34 M | $14.34 M |
| Dec 2019 | -$4.17 M(-54.5%) | - | - |
| Dec 2018 | -$9.17 M | - | - |
FAQ
- What is Maravai LifeSciences Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings annual CFF year-on-year change?
- What is Maravai LifeSciences Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings quarterly CFF year-on-year change?
- What is Maravai LifeSciences Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Maravai LifeSciences Holdings?
- What is Maravai LifeSciences Holdings TTM CFF year-on-year change?
What is Maravai LifeSciences Holdings annual cash flow from financing activities?
The current annual CFF of MRVI is -$61.09 M
What is the all time high annual CFF for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high annual cash flow from financing activities is $53.21 M
What is Maravai LifeSciences Holdings annual CFF year-on-year change?
Over the past year, MRVI annual cash flow from financing activities has changed by +$126.41 M (+67.42%)
What is Maravai LifeSciences Holdings quarterly cash flow from financing activities?
The current quarterly CFF of MRVI is $809.00 K
What is the all time high quarterly CFF for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high quarterly cash flow from financing activities is $40.67 M
What is Maravai LifeSciences Holdings quarterly CFF year-on-year change?
Over the past year, MRVI quarterly cash flow from financing activities has changed by +$26.00 K (+3.32%)
What is Maravai LifeSciences Holdings TTM cash flow from financing activities?
The current TTM CFF of MRVI is $947.00 K
What is the all time high TTM CFF for Maravai LifeSciences Holdings?
Maravai LifeSciences Holdings all-time high TTM cash flow from financing activities is $53.21 M
What is Maravai LifeSciences Holdings TTM CFF year-on-year change?
Over the past year, MRVI TTM cash flow from financing activities has changed by +$128.63 M (+100.74%)